Table 1. Baseline, procedural and outcome measures of the study population (n = 46).
| Baseline variables | |
| Age, years (mean, SD) | 61 (11) |
| Female, % (n) | 35 (16) |
| Body-mass index, kg/m2 (mean, SD) | 27 (3.5) |
| Anterior infarct location, % (n) | 46 (21) |
| Time-to-PCI, minutes (median, 25th, 75th percentile) | 152 (115, 280) |
| Procedural variables | |
| TIMI pre-procedural, % (n) | |
| 0 | 98 (45) |
| 1 | 2 (1) |
| TIMI after PCI, % (n) | |
| 2 | 6 (3) |
| 3 | 94 (43) |
| Medications | |
| Glycoprotein IIb/IIIa, % (n) | 78 (36) |
| Aspirin, % (n) | 98 (45) |
| Betablockers, % (n) | 100 (46) |
| Clopdiogrel, % (n) | 100 (46) |
| Outcomes | |
| Infarct size at 5 days, g (median, 25th, 75th percentile) | 35 (14, 53) |
| Infarct size at 4 months, g (median, 25th, 75th percentile) | 23 (6.0, 38) |
| LVEF at 5 days, % (median, 25th, 75th percentile) | 45 (40, 52) |
| LVEF at 4 months, % (median, 25th, 75th percentile) | 50 (45, 57) |
| EDVI at 5 days, ml3 (median, 25th, 75th percentile) | 79 (64, 87) |
| EDVI at 4 monhts, ml3 (median, 25th, 75th percentile) | 79 (63, 90) |
| ESVI at 5 days, ml3 (median, 25th, 75th percentile) | 44 (31, 50) |
| ESVI at 4 months, ml3 (median, 25th, 75th percentile) | 38 (28, 48) |
SD, standard deviation; PCI, percutaneous coronary intervention; TIMI, Thrombolysis In Myocardial Infarction; LVEF, left-ventricular ejection fraction; EDVI, end-diastolic volume index; ESVI, end-systolic volume index.